Geode Capital Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Other funds holding AVIR
BCM
Geode Capital Management's AVIR Position: Q3 2026 in Review
Geode Capital Management reduced its Atea Pharmaceuticals (AVIR) stake by 2.5% in Q3 2026, selling an estimated $246K and leaving 1,910,289 shares worth $10M. The position accounts for ﹤0.01% of the portfolio, ranked #2492.
Geode Capital Management first reported a position in AVIR in Q4 2020 and has held it in 24 quarters since. The position peaked at $36.2M in Q3 2021. 89 funds tracked by Wall St. Rank hold AVIR as of Q3 2026.
- Geode Capital Management held 1,910,289 shares of Atea Pharmaceuticals worth $10M as of Q3 2026.
- Geode Capital Management sold 48,146 Atea Pharmaceuticals shares in Q3 2026, an estimated $246K.
- Atea Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #2492 holding.
- Geode Capital Management first reported a position in Atea Pharmaceuticals in Q4 2020 and has held it in 24 quarters since.
- Geode Capital Management's Atea Pharmaceuticals position peaked at $36.2M in Q3 2021.
- 89 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.